Related Experiment Video

Updated: May 10, 2026

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells
06:55

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells

Published on: February 22, 2020

TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells

Annamaria Biroccio1, Julien Cherfils-Vicini, Adeline Augereau

  • 1Laboratory of Molecular Biology of the Cell, CNRS UMR5239, IFR128, Ecole Normale Supérieure de Lyon, Lyon 69364, France. biroccio@ifo.it

Nature Cell Biology
|June 25, 2013
PubMed

Insights

High levels of TRF2 in tumor cells hinder natural killer (NK) cell immunity, promoting cancer. Reducing TRF2 enhances NK cell activity and tumor elimination, revealing a novel cancer defense pathway.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Dysfunctional telomeres can inhibit tumor growth through cell-intrinsic mechanisms.
  • Elevated levels of TRF2 (Telomere Repeat Binding Factor 2) are linked to human cancers and oncogenesis.

Purpose of the Study:

  • To investigate the role of TRF2 in regulating natural killer (NK) cell activity in the context of cancer.
  • To identify mechanisms by which TRF2 influences the tumor microenvironment and immune surveillance.

Main Methods:

  • Assessing the impact of varying TRF2 levels on tumor cell interactions with NK cells.
  • Correlating TRF2 expression with NK cell density in early human colon cancer development.
  • Performing gene screening to identify TRF2-bound genes involved in NK cell recruitment.

Main Results:

  • High TRF2 levels in tumor cells reduced their capacity to recruit and activate NK cells.
  • Lowering TRF2 levels increased tumor cell susceptibility to NK cell-mediated elimination.
  • A correlation was observed between increasing TRF2 and decreasing NK cell density in early colon cancer.
  • HS3ST4 was identified as a TRF2-regulated gene that inhibits NK cell recruitment.

Conclusions:

  • TRF2 plays a critical role in suppressing anti-tumor immunity by inhibiting NK cell activity.
  • TRF2-dependent regulation of HS3ST4 represents a novel pathway impacting NK cell surveillance.
  • Targeting the TRF2-HS3ST4 pathway could offer new strategies for cancer immunotherapy.

More Related Videos

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro10:36

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro

Published on: January 9, 2018

Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia05:24

Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia

Published on: February 21, 2021

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...